Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Market Cap	75.49B
Revenue (ttm)	6.17B +34.4%
Net Income	1.68B +26.3%
EPS	15.40 +25.4%
Shares Out	112.95M
PE Ratio	43.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,059
Average Volume	113,010
Open	655.00
Previous Close	661.05
Day's Range	652.60 - 679.00
52-Week Range	524.05 - 795.00
Beta	n/a
RSI	64.50
Earnings Date	Feb 6, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 740
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUDEEPPHRM

Financial Performance

In fiscal year 2025, Sudeep Pharma's revenue was 5.02 billion, an increase of 9.30% compared to the previous year's 4.59 billion. Earnings were 1.39 billion, an increase of 4.14%.